JERICHO SCIENCES

jericho-sciences-logo

Jericho Sciences, LLC is focused on research and development of novel antiviral therapeutic and diagnostic products. Thier lead candidate compound exerts action via a viral peptide motif shared by many types of viruses, including human immunodeficiency virus (HIV-1) and feline immunodeficiency virus (FIV). While current combination antiretroviral therapy (cART) regimens can minimize disease progression by reducing viral loads for HIV-infected individuals, they do not address challenges posed by ... persistent viral reservoirs, therapeutically elusive physiological compartments and the development of drug resistance. New therapeutic agents useful to reduce persistent and elusive virus represent the next evolution for HIV treatment. Jericho Sciences collaborates with academic, government and industrial researchers and maintains a strong intellectual property position for all portfolio projects.

#People #Website #More

JERICHO SCIENCES

Social Links:

Industry:
Biotechnology Therapeutics

Address:
Nashville, Tennessee, United States

Country:
United States

Website Url:
http://www.jerichosciences.com

Total Employee:
1+

Status:
Active

Contact:
(703) 862-1700

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins Euro Office 365 Mail


Current Employees Featured

heidi-kay_image

Heidi Kay
Heidi Kay Founder & CEO @ Jericho Sciences
Founder & CEO
2006-01-01

Founder


heidi-kay_image

Heidi Kay

Official Site Inspections

http://www.jerichosciences.com

  • Host name: 184.0.153.160.host.secureserver.net
  • IP address: 160.153.0.184
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Jericho Sciences"

Jericho Sciences LLC โ€“ Antivirals and Clinically-Relevant Assays

Jericho Sciences is developing novel antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current therapies in the clinical โ€ฆSee details»

Jericho Sciences - Crunchbase Company Profile & Funding

Jericho Sciences, LLC is focused on research and development of novel antiviral therapeutic and diagnostic products. Thier lead candidate compound exerts action via a viral peptide motif โ€ฆSee details»

Who We Are โ€“ Jericho Sciences LLC

Heidi Kay is the Founder and CEO of Jericho Sciences, LLC. She is a lead inventor on multiple patents and has nearly 30 yearsโ€™ experience in cancer and antiviral research. She was formerly a faculty member at the University of โ€ฆSee details»

Jericho Sciences - PitchBook

Jericho Sciences General Information Description. Developer of antiviral therapeutic compounds and clinical diagnostic tools designed for novel antiviral therapeutics and corresponding โ€ฆSee details»

Jericho Sciences Company Profile | Management and Employees โ€ฆ

Www.jerichosciences.com . Contact Information. Headquarters. 2 Davis Dr, Durham, North Carolina, 27709, United States (703) 862-1700. Jericho Sciences Profile and History . Jericho โ€ฆSee details»

Heidi Kay - Founder and CEO - Jericho Sciences, LLC

Founder and CEO of Jericho Sciences, LLC · Accomplished startup Founder and CEO developing small molecule drugs and corresponding assays for โ€ฆSee details»

Jericho Sciences - Overview, News & Similar companies - ZoomInfo

Jericho Sciences contact info: Phone number: (703) 862-1700 Website: www.jerichosciences.com What does Jericho Sciences do? Jericho Sciences' mission is to advance scientific โ€ฆSee details»

Jericho Sciences, LLC - VentureRadar

"Jericho Sciences is developing a novel lead antiviral therapeutic small molecule demonstrating unique long term activities to specifically address the limitations of current combination โ€ฆSee details»

Home โ€“ Jericho Sciences LLC

Mission Statement Jericho Sciences is developing novel antiviral therapeutics and corresponding personalized diagnostic assays to support long term solutions.See details»

Jericho Sciences LLC: Drug pipelines, Patents, Clinical trials - Synapse

Aug 22, 2023 Explore Jericho Sciences LLC with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Infectious Diseases, Immune System Diseases, โ€ฆSee details»

Jericho Sciences LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Jericho Sciences LLC of Nashville, TN. Get the latest business insights from Dun & Bradstreet.See details»

Jericho Sciences in Durham, NC - (703) 862-1700 - Company Profile

Jericho Sciences is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»

Jericho Sciences Company Profile -Sales, Contacts, Competitors โ€“ โ€ฆ

Jericho Sciences is in the Medical Research industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for approximately 13 โ€ฆSee details»

Jericho Sciences, LLC - CMOCRO

Jericho Sciences, LLC is focused on research and development of novel antiviral therapeutic and diagnostic products in areas of high medical need.See details»

How to Contact Us โ€“ Jericho Sciences LLC

Please find Jerichoโ€™s Financial Conflict of Interest Policy here FCOI_2023 DownloadSee details»

Heidi Kay - Founder and CEO - JERICHO SCIENCES, LLC - Apollo.io

View Heidi Kay's business profile as Founder and CEO at JERICHO SCIENCES, LLC. Find Heidi's email address, mobile number, work history, and more.See details»

Heidi Kay Ph.D Profile: Contact Information & Network - PitchBook

Heidi Kay Ph.D General Information Biography. Dr. Heidi Kay is the Founder & serves as Chief Executive Officer at Jericho Sciences. She holds a strong patent portfolio in therapeutics and โ€ฆSee details»

News and Events โ€“ Jericho Sciences LLC

27 May 2024: Dr. Kay was selected as 1 of 26 members in the DC area cohort to participate in the 2024 SBA T.H.R.I.V.E. Emerging Leaders Reimagined Program through December 2024. This โ€ฆSee details»

Our Progress โ€“ Jericho Sciences LLC

Nonprovisional PCT application Methods for Viral Infections filed Feb 28, 2023.. Utilities of stimulated whole blood culture systems.US 10,550,419 · Issued Feb 4, 2020. Lipid Raft, โ€ฆSee details»

What We Do โ€“ Jericho Sciences LLC

Site Search. Search for: Search What We DoSee details»